U01HL146208
Cooperative Agreement
Overview
Grant Description
Covid-19 and the MWCCS: Pathophysiology, impact and outcomes.
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
Awarding Agency
Place of Performance
Pittsburgh,
Pennsylvania
152221808
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 33323% from $91,812 to $30,686,185.
University Of Pittsburgh - Of The Commonwealth System Of Higher Education was awarded
University of Pittsburgh MACS/WIHS CCS
Cooperative Agreement U01HL146208
worth $30,686,185
from the National Institute of Diabetes and Digestive and Kidney Diseases in April 2019 with work to be completed primarily in Pittsburgh Pennsylvania United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
The Cooperative Agreement was awarded through grant opportunity Limited Competition: Clinical Research Sites for MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01-Clinical Trials Not Allowed).
Status
(Ongoing)
Last Modified 7/21/25
Period of Performance
4/1/19
Start Date
3/31/26
End Date
Funding Split
$30.7M
Federal Obligation
$0.0
Non-Federal Obligation
$30.7M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01HL146208
Transaction History
Modifications to U01HL146208
Additional Detail
Award ID FAIN
U01HL146208
SAI Number
U01HL146208-80016618
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Awardee UEI
MKAGLD59JRL1
Awardee CAGE
1DQV3
Performance District
PA-12
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) | Health research and training | Grants, subsidies, and contributions (41.0) | $8,717,831 | 41% |
National Institute of Mental Health, National Institutes of Health, Health and Human Services (075-0892) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,793,580 | 13% |
National Institute on Aging, National Institutes of Health, Health and Human Services (075-0843) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,337,392 | 11% |
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Health and Human Services (075-0885) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,257,055 | 11% |
National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,805,454 | 8% |
Modified: 7/21/25